CoChat
Sign Up
Cited by 30

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Guidance for the clinical evaluation of traditional Chinese medicine-induced liver injuryIssued by China Food and Drug Administration

Xiao, Xiaohe, Tang, Jianyuan, Mao, Yimin, Li, Xiuhui, Wang, Jiabo, Liu, Chenghai, Sun, Kewei, Ye, Yong'an, Zou, Zhengsheng, Peng, Cheng, Yang, Ling, Guo, Yuming, Bai, Zhaofang, He, Tingting, Jing, Jing, Li, Fengyi, An, Na·2019·Acta Pharmaceutica Sinica B
DOI 10.1016/j.apsb.2018.12.003PMC PMC6543019
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.apsb.2018.12.003

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 49

  1. Miguel, 2012, Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta- analysis, Pharmacoepidemiol Drug Saf, 21, 1139, 10.1002/pds.3309 · DOI
  2. Andrade, 2006, Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry, Hepatology, 44, 1581, 10.1002/hep.21424 · DOI · Paper page
  3. Zhang, 2016, Systematic review on Chinese herbal medicine induced liver injury, Evid Based Complement Altern Med, 2016, 3560812, 10.1155/2016/3560812 · DOI · Paper page
  4. Chalasani, 2014, ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury, Am J Gastroenterol, 109, 950, 10.1038/ajg.2014.131 · DOI · Paper page
  5. Farah, 2000, International monitoring of adverse health effects associated with herbal medicines, Pharmacoepidemiol Drug Saf, 9, 105, 10.1002/(SICI)1099-1557(200003/04)9:2<105::AID-PDS486>3.0.CO;2-2 · DOI
  6. Wang, 2018, Guidelines for the diagnosis and management of herb-induced liver injury, Chin J Integr Med, 24, 696, 10.1007/s11655-018-3000-8 · DOI · Paper page
  7. Larrey, 2002, Epidemiology and individual susceptibility to adverse drug reactions affecting the liver, Semin Liver Dis, 22, 145, 10.1055/s-2002-30105 · DOI
  8. Bjornsson, 2014, Epidemiology and risk factors for idiosyncratic drug-induced liver injury, Semin Liver Dis, 34, 115, 10.1055/s-0034-1375953 · DOI
  9. López-Gil, 2017, Liver toxicity mechanisms of herbs commonly used in Latin America, Drug Metab Rev, 49, 338, 10.1080/03602532.2017.1335750 · DOI
  10. Valdivia-Correa, 2016, Herbal medicine in Mexico: a cause of hepatotoxicity, Int J Mol Sci, 17, 235, 10.3390/ijms17020235 · DOI
  11. Medina-Caliz, 2018, Herbal and dietary supplement-induced liver injuries in the Spanish DILI registry, Clin Gastroenterol Hepatol, 16, 1495, 10.1016/j.cgh.2017.12.051 · DOI · Paper page
  12. Vega, 2017, The incidence of drug- and herbal and dietary supplement-induced liver injury: preliminary findings from gastroenterologist-based surveillance in the population of the state of Delaware, Drug Saf, 40, 783, 10.1007/s40264-017-0547-9 · DOI · Paper page
  13. Jing, 2018, Traditional Chinese medicine and herb-induced liver injury: comparison with drug-induced liver injury, J Clin Transl Hepatol, 6, 57, 10.14218/JCTH.2017.00033 · DOI
  14. Navarro, 2017, Liver injury from herbal and dietary supplements, Hepatology, 65, 363, 10.1002/hep.28813 · DOI
  15. Cho, 2017, A nationwide study of the incidence rate of herb-induced liver injury in Korea, Arch Toxicol, 91, 4009, 10.1007/s00204-017-2007-9 · DOI · Paper page
  16. Xu, 2007, A multicenter survey on hospital inpatients with drug-induced acute liver injury in China, Chin J Dig, 27, 439
  17. Liu, 2017, Epidemic features, major causes, and diagnostic evaluation of herb-induced liver injury, Chin J Clin Hepatol, 33, 829
  18. Li, 2017, Screening for main components associated with the idiosyncratic hepatotoxicity of a tonic herb Polygonum multiflorum, Front Med, 11, 253, 10.1007/s11684-017-0508-9 · DOI
  19. Bai, 2017, Progress in research on the pathogenesis of immune regulation and idiosyncratic drug-induced liver injury, Acta Pharm Sin, 52, 1019
  20. Pais, 2014, The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease, Clin Liver Dis, 18, 165, 10.1016/j.cld.2013.09.015 · DOI
  21. Lucena, 2009, Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex, Hepatology, 49, 2001, 10.1002/hep.22895 · DOI · Paper page
  22. Suzman, 2018, Hepatotoxicity of immune checkpoint inhibitors: an evolving picture of risk associated with a vital class of immunotherapy agents, Liver Int, 38, 976, 10.1111/liv.13746 · DOI · Paper page
  23. He, 2017, Immunological synergistic mechanisms of trans-/cis-stilbene glycosides in Heshouwu related idiosyncratic liver injury, Sci Bull, 62, 748, 10.1016/j.scib.2017.04.020 · DOI
  24. Amin, 2015, Drug-induced liver injury in children, Curr Opin Pediatr, 27, 625, 10.1097/MOP.0000000000000264 · DOI · Paper page
  25. Chalasani, 2016, Drug-induced liver injury in patients with preexisting chronic liver disease in drug development: how to identify and manage?, Gastroenterology, 151, 1046, 10.1053/j.gastro.2016.10.010 · DOI
  26. Wang, 2011, Hepatotoxicity or hepatoprotection pattern recognition for the paradoxical effect of the Chinese herb Rheum palmatum L. in treating rat liver injury, PLoS One, 6, e24498, 10.1371/journal.pone.0024498 · DOI
  27. Xing, 2011, Investigation of the "dose-time-response" relationships of rhubarb on carbon tetrachloride-induced liver injury in rats, J Ethnopharmacol, 135, 575, 10.1016/j.jep.2011.03.053 · DOI
  28. Zhu, 2016, Analysis of clinical characteristics in 595 patients with herb-induced liver injury, Chin J Integr Med, 36, 44
  29. Zhu, 2016, Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients, J Gastroenterol Hepatol, 31, 1476, 10.1111/jgh.13323 · DOI · Paper page
  30. Lou, 2017, Recent advances in the diagnosis and risk assessment of drug-induced liver injury, Liver, 22, 774
  31. Clarke, 2016, Recent advances in biomarkers and therapeutic interventions for hepatic drug safety—false dawn or new horizon?, Exp Opin Drug Saf, 15, 625, 10.1517/14740338.2016.1160057 · DOI · Paper page
  32. Nicoletti, 2017, Association of liver injury from specific drugs, or groups of drugs, with polymorphisms in hla and other genes in a genome-wide association study, Gastroenterology, 152, 1078, 10.1053/j.gastro.2016.12.016 · DOI · Paper page
  33. Church RJ, Kullak-Ublick GA, Aubrecht J, Bonkovsky HL, Chalasani N, Fontana RJ, et al., Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: Hepatology 2018. Available from: https://doi.org/10.1002/hep.29802. · DOI · Paper page
  34. Zhang, 2014, Pharmacovigilance in China: current situation, successes and challenges, Drug Saf, 37, 765, 10.1007/s40264-014-0222-3 · DOI
  35. Tan EH, Low EXS, Dan YY, Tai BC. Systematic review and meta-analysis of algorithms used to identify drug-induced liver injury (DILI) in health record databases. Liver Int 2017. Available from: https://doi.org/10.1111/liv.13646. · DOI
  36. Jiang, 2013, Technical methods and application of traditional Chinese medicine toxicity evaluation, Prog Pharm Sci, 37, 545
  37. Wang, 2016, Precision medicine-oriented safety assessment strategy for traditional Chinese medicines: disease-syndrome-based toxicology, Acta Pharm Sin, 51, 1681
  38. Suzuki, 2011, The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury, Hepatology, 54, 931, 10.1002/hep.24481 · DOI · Paper page
  39. Kullak-Ublick, 2017, Drug-induced liver injury: recent advances in diagnosis and risk assessment, Gut, 66, 1154, 10.1136/gutjnl-2016-313369 · DOI · Paper page
  40. Shahbaz, 2017, Highlights of drug- and herb-induced liver injury in the literature from 2016: how best to translate new information into clinical practice?, Exp Opin Drug Metab Toxicol, 13, 935, 10.1080/17425255.2017.1362391 · DOI · Paper page
  41. Dakhoul, 2018, Drug-induced chronic liver injury, J Hepatol, 69, 248, 10.1016/j.jhep.2018.01.001 · DOI
  42. Wang, 2016, Integrated evidence chain-based identification of Chinese herbal medicine-induced hepatotoxicity and rational usage: exemplification by Polygonum Multiflorum (He shou wu), Chin Sci Bull, 61, 971, 10.1360/N972015-01289 · DOI
  43. He, 2016, Clinical analysis of two diagnosis methods for herb-induced liver injury, Chin J Chin Mat Med, 41, 3096
  44. Danan, 1993, Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: application to drug induced liver injuries, J Clin Epidemiol, 46, 1323, 10.1016/0895-4356(93)90101-6 · DOI · Paper page
  45. Danan, 2016, RUCAM in drug and herb induced liver injury: the update, Int J Mol Sci, 17, 14, 10.3390/ijms17010014 · DOI · Paper page
  46. Wang, 2015, Evidence chain-based causality identification in herb-induced liver injury: exemplification of a well-known liver-restorative herb Polygonum multiflorum, Front Med, 9, 457, 10.1007/s11684-015-0417-8 · DOI · Paper page
  47. Wang, 2018, Causality assessment strategies and methods for Chinese medicines-induced liver injury, Acta Pharm Sin, 53, 920
  48. Xiao, 2018, Pharmaceutical diseases and their risk prevention and control, Prog Pharm Sci, 42, 161
  49. Raschi, 2015, Drug- and herb-induced liver injury: progress, current challenges and emerging signals of post-marketing risk, World J Hepatol, 7, 1761, 10.4254/wjh.v7.i13.1761 · DOI

Cited by

Sorted by citations

Metadata

Authors
Xiao, X., Tang, J., Mao, Y., Li, X., Wang, J., Liu, C., Sun, K., Ye, Y., Zou, Z., Peng, C., Yang, L., Guo, Y., Bai, Z., He, T., Jing, J., Li, F., & An, N.
Venue
Acta Pharmaceutica Sinica B
Publisher
Elsevier BV
Published
2019-05
Volume
9
Issue
3
Pages
648-658
ISSN
2211-3835
DOI
10.1016/j.apsb.2018.12.003
PMC
PMC6543019
Cited by
30
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review